|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-4-13
|
|
pubmed:abstractText |
The myometrial hyperactivity and reduced uterine blood flow of primary dysmenorrhea is to a large extent caused by increased vasopressin secretion. A new therapeutic approach for this condition is to develop antagonists of uterine vasopressin V1a receptors. We studied a test model of vasopressin-induced dysmenorrhea in healthy, sterilized women and compared responses against those in dysmenorrheic subjects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0001-6349
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
451-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16612708-Adult,
pubmed-meshheading:16612708-Cross-Over Studies,
pubmed-meshheading:16612708-Double-Blind Method,
pubmed-meshheading:16612708-Dysmenorrhea,
pubmed-meshheading:16612708-Female,
pubmed-meshheading:16612708-Humans,
pubmed-meshheading:16612708-Infertility, Female,
pubmed-meshheading:16612708-Pain Measurement,
pubmed-meshheading:16612708-Placebos,
pubmed-meshheading:16612708-Pressure,
pubmed-meshheading:16612708-Uterus,
pubmed-meshheading:16612708-Vasopressins
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Validation of a test model of induced dysmenorrhea.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University Hospital of Lund, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
